252 related articles for article (PubMed ID: 16890726)
1. Preparation of a single prostate needle biopsy specimen for histological diagnosis and RNA analysis.
Fukabori Y; Yoshida K; Nakano K; Shibata Y; Yamanaka H; Oyama T
J Urol; 2006 Sep; 176(3):1204-7. PubMed ID: 16890726
[TBL] [Abstract][Full Text] [Related]
2. The role of prostate specific membrane antigen and pepsinogen C tissue expression as an adjunctive method to prostate cancer diagnosis.
Antunes AA; Leite KR; Sousa-Canavez JM; Camara-Lopes LH; Srougi M
J Urol; 2009 Feb; 181(2):594-600. PubMed ID: 19084862
[TBL] [Abstract][Full Text] [Related]
3. Increasing the number of biopsies increases the concordance of Gleason scores of needle biopsies and prostatectomy specimens.
Divrik RT; Eroglu A; Sahin A; Zorlu F; Ozen H
Urol Oncol; 2007; 25(5):376-82. PubMed ID: 17826653
[TBL] [Abstract][Full Text] [Related]
4. The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer.
Schoenfield L; Jones JS; Zippe CD; Reuther AM; Klein E; Zhou M; Magi-Galluzzi C
BJU Int; 2007 Apr; 99(4):770-4. PubMed ID: 17233800
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical evaluation of prostate needle biopsies using saved interval sections vs new recut sections from the block: a prospective comparison.
Hameed O; Humphrey PA
Am J Clin Pathol; 2009 May; 131(5):683-7. PubMed ID: 19369628
[TBL] [Abstract][Full Text] [Related]
6. PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy.
Marks LS; Fradet Y; Deras IL; Blase A; Mathis J; Aubin SM; Cancio AT; Desaulniers M; Ellis WJ; Rittenhouse H; Groskopf J
Urology; 2007 Mar; 69(3):532-5. PubMed ID: 17382159
[TBL] [Abstract][Full Text] [Related]
7. TP53 mutation in prostate needle biopsies--comparison with patients follow-up.
Ecke TH; Schlechte HH; Hübsch A; Lenk SV; Schiemenz K; Rudolph BD; Miller K
Anticancer Res; 2007; 27(6B):4143-8. PubMed ID: 18225585
[TBL] [Abstract][Full Text] [Related]
8. The prostate needle biopsy gun: busting a myth.
Patel AR; Jones JS
J Urol; 2007 Aug; 178(2):683-5. PubMed ID: 17574615
[TBL] [Abstract][Full Text] [Related]
9. PCA3 score before radical prostatectomy predicts extracapsular extension and tumor volume.
Whitman EJ; Groskopf J; Ali A; Chen Y; Blase A; Furusato B; Petrovics G; Ibrahim M; Elsamanoudi S; Cullen J; Sesterhenn IA; Brassell S; Rittenhouse H; Srivastava S; McLeod DG
J Urol; 2008 Nov; 180(5):1975-8; discussion 1978-9. PubMed ID: 18801539
[TBL] [Abstract][Full Text] [Related]
10. Aberrant diffuse expression of p63 in adenocarcinoma of the prostate on needle biopsy and radical prostatectomy: report of 21 cases.
Osunkoya AO; Hansel DE; Sun X; Netto GJ; Epstein JI
Am J Surg Pathol; 2008 Mar; 32(3):461-7. PubMed ID: 18300803
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of constructing tissue microarrays from diagnostic prostate biopsies.
Singh SS; Mehedint DC; Ford OH; Maygarden SJ; Ruiz B; Mohler JL
Prostate; 2007 Jul; 67(10):1011-8. PubMed ID: 17476688
[TBL] [Abstract][Full Text] [Related]
12. Detection of prostate cancer via biopsy in the Medicare-SEER population during the PSA era.
Welch HG; Fisher ES; Gottlieb DJ; Barry MJ
J Natl Cancer Inst; 2007 Sep; 99(18):1395-400. PubMed ID: 17848671
[TBL] [Abstract][Full Text] [Related]
13. Background, methods, and protocols for the histopathological diagnosis of prostate carcinoma.
Delprado W
Methods Mol Med; 2003; 81():181-97. PubMed ID: 12725121
[No Abstract] [Full Text] [Related]
14. Formamide as a denaturant for bisulfite conversion of genomic DNA: Bisulfite sequencing of the GSTPi and RARbeta2 genes of 43 formalin-fixed paraffin-embedded prostate cancer specimens.
Zon G; Barker MA; Kaur P; Groshen S; Jones LW; Imam SA; Boyd VL
Anal Biochem; 2009 Sep; 392(2):117-25. PubMed ID: 19505431
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial genome deletion aids in the identification of false- and true-negative prostate needle core biopsy specimens.
Maki J; Robinson K; Reguly B; Alexander J; Wittock R; Aguirre A; Diamandis EP; Escott N; Skehan A; Prowse O; Thayer RE; Froberg MK; Wilson MJ; Maragh S; Jakupciak JP; Wagner PD; Srivastava S; Dakubo GD; Parr RL
Am J Clin Pathol; 2008 Jan; 129(1):57-66. PubMed ID: 18089489
[TBL] [Abstract][Full Text] [Related]
16. Exercise and prostate cancer risk in a cohort of veterans undergoing prostate needle biopsy.
Antonelli JA; Jones LW; Bañez LL; Thomas JA; Anderson K; Taylor LA; Gerber L; Anderson T; Hoyo C; Grant D; Freedland SJ
J Urol; 2009 Nov; 182(5):2226-31. PubMed ID: 19758620
[TBL] [Abstract][Full Text] [Related]
17. Role of fine needle aspiration cytology (FNAC) in the diagnosis of prostatic lesions with histologic correlation.
Saleh AF; Nahar Rahman AJ; Salam MA; Islam F
Bangladesh Med Res Counc Bull; 2005 Dec; 31(3):95-103. PubMed ID: 17549870
[TBL] [Abstract][Full Text] [Related]
18. The proportion of cores with high-grade prostatic intraepithelial neoplasia on extended-pattern needle biopsy is significantly associated with prostate cancer on site-directed repeat biopsy.
Akhavan A; Keith JD; Bastacky SI; Cai C; Wang Y; Nelson JB
BJU Int; 2007 Apr; 99(4):765-9. PubMed ID: 17378840
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of restaining prostate needle biopsies with high-molecular weight cytokeratin.
Dardik M; Epstein JI
Hum Pathol; 2000 Sep; 31(9):1155-61. PubMed ID: 11014585
[TBL] [Abstract][Full Text] [Related]
20. Prediction of pathological stages before prostatectomy in prostate cancer patients: analysis of 12 systematic prostate needle biopsy specimens.
Park EA; Lee HJ; Kim KG; Kim SH; Lee SE; Choe GY
Int J Urol; 2007 Aug; 14(8):704-8. PubMed ID: 17681059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
